Axcelis Technologies, Inc. $ACLS Shares Sold by Comerica Bank

Comerica Bank lessened its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 3.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,135 shares of the semiconductor company’s stock after selling 400 shares during the quarter. Comerica Bank’s holdings in Axcelis Technologies were worth $553,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in ACLS. BNP Paribas Financial Markets increased its stake in shares of Axcelis Technologies by 305.4% during the fourth quarter. BNP Paribas Financial Markets now owns 116,290 shares of the semiconductor company’s stock valued at $8,125,000 after acquiring an additional 87,602 shares during the period. Bank of America Corp DE grew its position in Axcelis Technologies by 104.4% in the fourth quarter. Bank of America Corp DE now owns 285,284 shares of the semiconductor company’s stock worth $19,933,000 after buying an additional 145,701 shares during the last quarter. Deutsche Bank AG grew its position in Axcelis Technologies by 52.0% in the fourth quarter. Deutsche Bank AG now owns 28,487 shares of the semiconductor company’s stock worth $1,990,000 after buying an additional 9,741 shares during the last quarter. Graham Capital Management L.P. grew its position in Axcelis Technologies by 83.9% in the fourth quarter. Graham Capital Management L.P. now owns 5,178 shares of the semiconductor company’s stock worth $362,000 after buying an additional 2,363 shares during the last quarter. Finally, Gotham Asset Management LLC grew its position in Axcelis Technologies by 110.0% in the fourth quarter. Gotham Asset Management LLC now owns 23,990 shares of the semiconductor company’s stock worth $1,676,000 after buying an additional 12,568 shares during the last quarter. Institutional investors and hedge funds own 89.98% of the company’s stock.

Analyst Ratings Changes

ACLS has been the topic of several recent research reports. B. Riley lifted their price target on shares of Axcelis Technologies from $58.00 to $75.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 18th. DA Davidson lifted their price target on shares of Axcelis Technologies from $75.00 to $90.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $90.00.

Axcelis Technologies Trading Up 2.3%

NASDAQ ACLS opened at $80.61 on Monday. Axcelis Technologies, Inc. has a twelve month low of $40.40 and a twelve month high of $110.17. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.26 and a current ratio of 6.01. The stock has a market cap of $2.53 billion, a price-to-earnings ratio of 16.48 and a beta of 1.73. The firm’s 50 day moving average price is $76.20 and its two-hundred day moving average price is $63.55.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.40. The firm had revenue of $194.54 million for the quarter, compared to analysts’ expectations of $185.15 million. Axcelis Technologies had a net margin of 17.69% and a return on equity of 16.26%. The company’s quarterly revenue was down 24.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.55 EPS. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. Equities analysts anticipate that Axcelis Technologies, Inc. will post 2.55 EPS for the current year.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.